Pharmacovigilance of drug allergy and hypersensitivity using the ENDA–DAHD database and the GA2LEN platform. The Galenda project
- 21 January 2009
- Vol. 64 (2), 194-203
- https://doi.org/10.1111/j.1398-9995.2008.01944.x
Abstract
Nonallergic hypersensitivity and allergic reactions are part of the many different types of adverse drug reactions (ADRs). Databases exist for the collection of ADRs. Spontaneous reporting makes up the core data‐generating system of pharmacovigilance, but there is a large under‐estimation of allergy/hypersensitivity drug reactions. A specific database is therefore required for drug allergy and hypersensitivity using standard operating procedures (SOPs), as the diagnosis of drug allergy/hypersensitivity is difficult and current pharmacovigilance algorithms are insufficient. Although difficult, the diagnosis of drug allergy/hypersensitivity has been standardized by the European Network for Drug Allergy (ENDA) under the aegis of the European Academy of Allergology and Clinical Immunology and SOPs have been published. Based on ENDA and Global Allergy and Asthma European Network (GA2LEN, EU Framework Programme 6) SOPs, a Drug Allergy and Hypersensitivity Database (DAHD®) has been established under FileMaker® Pro 9. It is already available online in many different languages and can be accessed using a personal login. GA2LEN is a European network of 27 partners (16 countries) and 59 collaborating centres (26 countries), which can coordinate and implement the DAHD across Europe. The GA2LEN–ENDA–DAHD platform interacting with a pharmacovigilance network appears to be of great interest for the reporting of allergy/hypersensitivity ADRs in conjunction with other pharmacovigilance instruments.This publication has 52 references indexed in Scilit:
- A case‐control study of the relation between plasma selenium and asthma in European populations: a GA2LEN project*Allergy, 2008
- Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR StudyJournal of the American Academy of Dermatology, 2008
- Oral challenges are needed in the diagnosis of β‐lactam hypersensitivityClinical & Experimental Allergy, 2007
- Continued need of appropriate betalactam‐derived skin test reagents for the management of allergy to betalactamsClinical & Experimental Allergy, 2007
- Standard skin prick testing and sensitization to inhalant allergens across Europe – a survey from the GA2LEN network*Allergy, 2005
- Management of hypersensitivity reactions to iodinated contrast mediaAllergy, 2005
- Drug-Induced AnaphylaxisDrug Safety, 2005
- Using MedDRADrug Safety, 2004
- Adverse Drug Reactions Related to the Use of NSAIDs with a Focus on NimesulideDrug Safety, 2001
- The Medical Dictionary for Regulatory Activities (MedDRA)Drug Safety, 1999